Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)

Name

Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)

Legal name

Kumasi Centre for Collaborative Research in Tropical Medicine

Website

https://kccr-ghana.org

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Tropical Medicine Research Services

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Analytical Instruments & Chromatography Systems (HLAGAIAA), DMPK / ADME & Bioanalysis (HLAGAFAC)

Keywords

• Tropical medicine research
• Biomedical diagnostics
• Clinical trial services
• Infectious disease research
• Laboratory testing services

Headquarters

HQ city

Kumasi, Ashanti Region

HQ country

Ghana

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Research Grants and Funding: KCCR operates primarily as a research institution funded through acquisition of research grants from international funding bodies and partnerships.
2. Diagnostic Services: Laboratory and diagnostic services for COVID-19 testing and other disease diagnostics serving the middle and northern belts of Ghana.
3. Workshop and Training Fees: Professional development workshops such as the BASES workshop with registration fees of GHS 1,500 per participant.

Pricing tiers

Distribution channels3 records

Marketing channels7 records

Core offering

KCCR is a tropical medicine research institution that conducts biomedical and clinical research on infectious and neglected tropical diseases while delivering laboratory diagnostic services, clinical trial support, and postgraduate training. Its service portfolio spans molecular biology, bacteriology, immunology, parasitology, entomology, and cryopreservation, supported by BSL-2/BSL-3 laboratories. As a WHO Reference Laboratory for Buruli Ulcer and a designated COVID-19 diagnostic centre for middle and northern Ghana, KCCR functions as both a research platform and a public-health diagnostic provider.

Product overview

KCCR is a biomedical research institution offering a unified portfolio of laboratory diagnostic services, clinical research capabilities, and training programs. The core offering centers on laboratory services spanning molecular biology, bacteriology, immunology, entomology, parasitology, and cryopreservation, supported by BSL-2/BSL-3 laboratory facilities. Clinical trials services and diverse research groups address tropical diseases including Buruli ulcer, malaria, COVID-19, and antimicrobial resistance. The institution also provides capacity building through postgraduate training, short courses, and seminars. Supporting infrastructure includes guest house, seminar facilities, and transport services.

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory & Diagnostic Services

Quantifiable outcome

• First African institution recognized within LEO Foundation's grantee geography
• +1 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

14 partnerships are on record, tiered core, major and emerging.

• Bernhard Nocht Institute for Tropical Medicine (BNITM)coreStrategic or Co-development Partner · 1 January 1997Core founding partner and co-initiator of KCCR alongside KNUST School of Medical Sciences and Ministry of Health Ghana. BNITM is Germany's largest institution for tropical medicine research. Provides ongoing scientific leadership, research collaboration, and institutional support. Prof. Jürgen May serves as Chairman of BNITM Foundation.
• Kwame Nkrumah University of Science and Technology (KNUST)coreStrategic or Co-development PartnerCore founding partner hosting KCCR on its campus. KNUST School of Medical Sciences provides academic affiliation and student pipeline. Prof. Christian Agyare serves as Vice-Chancellor of KNUST.
• Ministry of Health GhanacoreStrategic or Co-development PartnerCore founding partner providing governmental oversight and health policy alignment. Dr. Adam Hafez Taher serves as Director For Technical Coordination at MOH.
• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO designation as reference laboratory for Buruli Ulcer diagnosis. Collaborated on clinical trials assessment with National Vaccine Institute in August 2026. Ongoing partnerships in infectious disease research and surveillance.
• National Vaccine Institute (NVI)coreStrategic or Co-development PartnerNVI assessors and monitors engaged KCCR in August 2026 to pilot Clinical Trial Institution Capability Self-Assessment Tool. Partnership focused on strengthening Ghana's clinical trials ecosystem.
• Charité - Universitätsmedizin BerlinmajorStrategic or Co-development PartnerPartnership on COVISEQ project establishing virological and immunological laboratory methods for viral vaccine candidates. Recruitng technician for animal testing facility.
• University of KentmajorStrategic or Co-development PartnerCollaboration through Infectious Disease Epidemiology Research Group on proposed joint study. Prof. Anastasios Tsaousis leads Laboratory of Molecular and Evolutionary Parasitology research on Cryptosporidium and Blastocystis.
• German Academic Exchange Service (DAAD)majorStrategic or Co-development PartnerDAAD Regional Office in Accra participates in Higher Education Policy Visit to KNUST/KCCR. Supports German-Ghana academic exchange and research cooperation.
• SartoriusemergingTechnology or IntegrationMarch 2026 engagement exploring collaboration in training, capacity building, use of virtual reality in scientific education, and co-investment in advanced research infrastructure.
• University of Hamburg / BNITMmajorStrategic or Co-development PartnerMaster's student Elisa Muller from University of Hamburg affiliated with BNITM conducted wastewater surveillance research placement at KCCR's One Health Bacteriology Group.
• University of BonnmajorStrategic or Co-development PartnerCollaborating on TAKeOFF-KCCR Partner Site. PhD student Alexandra Humpert delivered seminar on qualitative research. Prof. Alexander Yaw Debrah leads TAKeOFF Consortium.
• King's College LondonmajorStrategic or Co-development PartnerDr. Ellis K. Paintsil from Roger Williams Institute of Liver Studies delivers seminar on antimicrobial resistance in cirrhosis. Prof. Debbie Shawcross conducted seminar on gut microbiome research.
• German Center for Infection Research (DZIF)majorStrategic or Co-development PartnerCollaboration on BASES workshop alongside BNITM. Supports infectious disease research training and capacity building.
• Drugs for Neglected Diseases initiative (DNDi)majorStrategic or Co-development PartnerInternational non-profit organization developing treatments for neglected diseases, collaborating on clinical research.

Scale indicators8 records

Recent moves1 record

Direct peers

• Ifakara Health Institute: Tanzanian tropical health research institute with strong entomology/parasitology and clinical trial capability. Comparable as another East African peer with WHO collaborations and grant-funded tropical disease research, useful for benchmarking.
• Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW): Wellcome Trust-funded tropical medicine/clinical trial centre in Malawi with international partnerships. Closely comparable as a Sub-Saharan African research centre running clinical trials, postgraduate training, and diagnostics under a tripartite UK/Malawi/Wellcome model similar to KCCR's KNUST/BNITM/MoH structure.
• Bernhard Nocht Institute for Tropical Medicine (BNITM): German tropical medicine research institute and a KCCR founding partner. Highly comparable by virtue of shared scientific platforms (virology, bacteriology, parasitology), joint project pipelines, and governance entanglement through BNITM Foundation chair.
• Noguchi Memorial Institute for Medical Research (NMIMR): Ghana's other premier biomedical research institute, located at the University of Ghana, Legon. Compares directly as a national tropical medicine/infectious disease research center with BSL labs, surveillance, and graduate training — KCCR's closest domestic peer.
• MRC Unit The Gambia at London School of Hygiene & Tropical Medicine: West African clinical research centre with BSL labs, vaccine trial capability, and tropical disease focus. Directly comparable as a grant-funded African research institution running clinical trials, diagnostics, and postgraduate training.

Others

• QIAGEN: Supplier of molecular diagnostics and PCR sample-prep technologies used inside KCCR's molecular biology labs. Comparable as the technology vendor whose consumables and instrumentation underpin KCCR's molecular diagnostic service line.

Broad incumbents

• Pasteur Institute (Institut Pasteur): Global reference laboratory network for infectious disease with WHO collaborating centre status. Comparable in terms of disease-area reference laboratory positioning and diagnostic training, though at vastly larger scale.
• Kenya Medical Research Institute (KEMRI): Kenya's national medical research body with much broader scope, multiple centres, and substantial BSL-3 capacity. Comparable as a larger-scale African tropical/infectious disease research institution that KCCR could partner with or benchmark against.
• Centre for Tropical Medicine and Global Health, University of Oxford: Global academic centre for tropical medicine with extensive clinical trial networks across Africa and Asia. Comparable as a node in international consortia (similar to KCCR's network role) and as a potential senior partner.

Emerging players

• Drugs for Neglected Diseases initiative (DNDi): International non-profit drug developer for neglected tropical diseases and a current KCCR partner. Closely comparable as an NTD-focused research/development organization running clinical trials in lower- and middle-income countries.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC8wp4SQb__nTtLFOAcM8tuQ
• Facebookweb.facebook.com/profile.php?id=100087055116000
• LinkedInlinkedin.com/company/kumasi-center-for-collaborative-research-in-tropical-medicine
• Instagraminstagram.com/kccrknust
• Xtwitter.com/KCCR_GH

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR)